David Lansky & Jeff Micklos
Care management should be payer-agnostic at its core.
JP Sharp, Patrick H. Conway & Rahul Rajkumar
We believe North Carolina can be a model for the nation.
Nicholas Bagley, Amitabh Chandra, Craig Garthwaite & Ariel D. Stern
Three proposals for improving the law to reflect 21st-century drug development practices.
Dana P. Goldman, Karen Van Nuys, Wei-Han Cheng, Jakub P. Hlávka, Luca Pani, Sylvain Chassang & Erik Snowberg
Are we paying too much for new drugs before we know how well they work? This innovative pricing model proposes postponing major rewards until efficacy is established — which could help both patients and payers while still paying back investments on the most effective drugs.
Insights Report by
NEJM Catalyst & University of Utah Health
An independent NEJM Catalyst report sponsored by University of Utah Health on patient involvement in quality measurement.
Case Study by
John Grady-Benson, Michael Cremins, Elizabeth Olson, Nishwant Swami & Steven Schutzer
The Connecticut Joint Replacement Institute has demonstrated that formerly competing independent providers can unite on a common vision to yield drastic improvements in quality, safety, and costs.
Case Study by
Patrick Cronin, Shailesh Dominic Aranha & Alexa Boer Kimball
Actionable data and modest financial incentives can help motivate clinicians to adjust their behavior around scheduling follow-up appointments.
NEJM Catalyst Insights Council members weigh in on the barriers and path forward to value-based health care.
Primary care must leverage disruptive innovations to ensure that patients receive first-access, comprehensive, coordinated, continuous care that is woven into a seamlessly integrated system.
Jeffrey S. Berns, Aaron Glickman & Matthew S. McCoy
Despite potential benefits, joint ventures between nephrologists and dialysis companies raise legal and ethical concerns because of participants’ conflicts of interest and lack of transparency.